Exane Derivatives’s Estee Lauder EL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$565K Sell
2,221
-722
-25% -$183K 0.33% 70
2022
Q1
$801K Buy
2,943
+74
+3% +$22.3K 0.23% 121
2021
Q4
$1.06M Buy
2,869
+2,865
+71,625% +$972K 0.26% 85
2021
Q3
$1.2K Hold
4
﹤0.01% 841
2021
Q2
$1.28K Hold
4
﹤0.01% 852
2021
Q1
$1.16K Hold
4
﹤0.01% 719
2020
Q4
$1.06K Hold
4
﹤0.01% 670
2020
Q3
$873 Sell
4
-729
-99% -$150K ﹤0.01% 629
2020
Q2
$138K Sell
733
-736
-50% -$132K 0.04% 247
2020
Q1
$234K Buy
1,469
+1,145
+353% +$221K 0.07% 180
2019
Q4
$70.8K Buy
324
+260
+406% +$50.5K 0.01% 342
2019
Q3
$12.7K Buy
64
+60
+1,500% +$11.5K ﹤0.01% 419
2019
Q2
$732 Buy
+4
New +$683 ﹤0.01% 573
2017
Q4
Sell
-1
Closed -$108 620
2017
Q3
$108 Sell
1
-22,328
-100% -$2.29M ﹤0.01% 504
2017
Q2
$2.14M Buy
22,329
+22,324
+446,480% +$2.05M 0.46% 56
2017
Q1
$424 Sell
5
-1,942
-100% -$160K ﹤0.01% 433
2016
Q4
$149K Buy
+1,947
New +$158K 0.03% 217

Other funds holding EL

Exane Derivatives's EL Position: Q2 2022 in Review

Exane Derivatives reduced its Estee Lauder (EL) stake by 25% in Q2 2022, selling an estimated $183K and leaving 2,221 shares worth $565K. The position accounts for 0.33% of the portfolio, ranked #70.

Exane Derivatives first reported a position in EL in Q4 2016 and has held it in 17 quarters since. The position peaked at $2.14M in Q2 2017. 1,155 funds tracked by Wall St. Rank hold EL as of Q2 2022.

  • Exane Derivatives held 2,221 shares of Estee Lauder worth $565K as of Q2 2022.
  • Exane Derivatives sold 722 Estee Lauder shares in Q2 2022, an estimated $183K.
  • Estee Lauder made up 0.33% of Exane Derivatives's portfolio in Q2 2022, its #70 holding.
  • Exane Derivatives first reported a position in Estee Lauder in Q4 2016 and has held it in 17 quarters since.
  • Exane Derivatives's Estee Lauder position peaked at $2.14M in Q2 2017.
  • 1,155 funds tracked by Wall St. Rank held Estee Lauder as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.